• BINODENOSON CHEMBL1950554

    Alternate Names:

    WRC-0470
    Binodenoson
    MRE0470
    (2R,3R,4S,5R)-2-[6-AMINO-2-[(2Z)-2-(CYCLOHEXYLMETHYLIDENE)HYDRAZINYL]PURIN-9-YL]-5-(HYDROXYMETHYL)OXOLANE-3,4-DIOL
    (2R,3R,4S,5R)-2-[6-AMINO-2-((2E)-2-(CYCLOHEXYLMETHYLIDENE)HYDRAZINYL)PURIN-9-YL]-5-(HYDROXYMETHYL)OXOLANE-3,4-DIOL
    NU006775
    NU001890
    ZINC3932652
    GTPL5595
    AC1O5RQH
    144348-08-3
    6439470
    MRE 0470
    2-((Cyclohexylmethylene)hydrazino)adenosine
    DB04853
    CTK8G9697
    ADENOSINE,2-[2-(CYCLOHEXYLMETHYLENE)HYDRAZINYL]-
    71345685
    ACMC-20N3WP
    D03120
    LS-15118
    ZINC13819003
    BINODENOSON [USAN:INN:BAN]
    LJA4M1L5LG
    BINODENOSON (USAN/INN)
    BINODENOSON [USAN]
    2-(CYCLOHEXYLMETHYLIDENEHYDRAZINO)ADENOSINE
    2- ADENOSINE
    2-(2-(CYCLOHEXYLMETHYLENE)DIAZANYL)-9-BETA-D-RIBOFURANOSYL-9H-PURIN-6-AMINE
    ADENOSINE, 2-((CYCLOHEXYLMETHYLENE)HYDRAZINO)-
    MRE-0470
    SHA-174
    WRC 0470
    UNII-LJA4M1L5LG
    9576912
    178102230
    5595
    DB-063536
    CTK4C4045
    SCHEMBL724955
    132624

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications diagnostic agent
    Drug Categories ribonucleosides
    Drug Categories purines
    Drug Categories purinergic p1 receptor agonists
    Drug Categories purinergic agonists
    Drug Categories purinergic agents
    Drug Categories purine nucleosides
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories nucleosides
    Drug Categories nucleic acids, nucleotides, and nucleosides
    Drug Categories neurotransmitter agents
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories heterocyclic compounds, 2-ring
    Drug Categories heterocyclic compounds
    Drug Categories glycosides
    Drug Categories chemical actions and uses
    Drug Categories carbohydrates
    Drug Groups investigational
    Drug Type small molecule
    (4 More Sources)